Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure. (Q45228825)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2005
edit
Language Label Description Also known as
English
Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure.
scientific article published in February 2005

    Statements

    Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit